KR7128940004
KR7128940004
HanmiPharm
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 1.547.531.098.760 | 1.495.501.575.560 | 3.5% |
| Cost of Revenue | 663.124.174.430 | 678.464.579.520 | 2.3% |
| Gross Profit | 884.406.924.330 | 817.036.996.040 | 8.2% |
| 626.607.833.000 | 600.850.808.000 | 4.3% | |
| Operating Income | 257.799.091.330 | 216.186.188.040 | 19.2% |
| Pretax Income | 213.477.735.470 | 171.253.974.790 | 24.7% |
| Net Income Common Stockholders | 169.554.330.030 | 121.315.102.380 | 39.8% |
| -- | -- | -- | |
| -- | -- | -- |